Nutex Health Inc. (NUTX) stock
NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3069% below fair value
$173.67+2.26 (+1.32%)
Close on Nov 13, 2026Market cap $1.19BP/E 7.4Yield –
Nutex Health price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Nutex Health's price to sales ratio was 1.5× on Nov 11, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.4× to 336.9×, with a median of 1.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.5× | +0.4 |
| 2025 | Dec 31, 2025 | 1.2× | +0.6 |
| 2024 | Dec 31, 2024 | 0.6× | +0.0 |
| 2023 | Dec 29, 2023 | 0.5× | −4.9 |
| 2022 | Dec 30, 2022 | 5.4× | −2.9 |
| 2021 | Dec 31, 2021 | 8.2× | −75.2 |
| 2020 | Dec 31, 2020 | 83.5× | +69.3 |
| 2019 | Dec 31, 2019 | 14.2× | – |
See a number that looks wrong?